Study of phospholipid profile of ovarian tumor by high performance liquid chromatography-mass spectrometry

Chinese Journal of Chromatography (Se Pu)

Volumn 29, Issue 9, 2011, Pages 843-850

  Zhao, Sumin ^a,d   Wang, Yisheng ^b   Dou, Abo ^a   Chen, Jing ^a   Lu, Xin ^a   Cao, Rui ^c   Xu, Congjian ^b   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b FUDAN UNIVERSITY   (China)

^c Dalian Obstetrics and Gynecology Hospital   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Liquid chromatography mass spectrometry (LC MS); Ovarian cancer; Ovarian tumor; Phospholipid profile

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ARTICLE; BLOOD; CLASSIFICATION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLOME; METHODOLOGY; OVARY TUMOR;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; LYSOPHOSPHATIDYLCHOLINES; METABOLOME; OVARIAN NEOPLASMS; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84859378624     PISSN: 10008713     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1123.2011.00843     Document Type: Article

References (33)

1. Williams T I, Toups K L, Saggese D A. et al. J Proteome Res, 2007, 6(8): 2936.
2. Jacobs I J, Menon U. Mol Cell Proteomies, 2004, 3(4): 355.
3. Kopczynski Z, Kuzniak J, Thielemann A, et al. Br J Cancer, 1998, 78(4): 466.
4. Okita M. Gaudette D C, Mills G B, et al. Int J Cancer, 1997, 71(1): 31.
5. Qadir M I, Malik S A. Eur J Gynaecol Oncol, 2008, 29(2): 158.
6. Gadomska H, Grzechocinska B, Janecki J, et al. Eur J Obstet Gyn R B, 2005, 120(1): 87.
7. Odunsi K, Wollman R M, Ambrosone C B, et al. Int J Cancer, 2005, 113(5): 782.
8. Chen J, Zhang X Y, Cao R, et al. J Proteome Res, 2011, 10(5): 2625.
9. Denkert C, Budczies J, Kind T, et al. Cancer Res, 2006, 66(22): 10795.
10. Woo H M, Kim K M, Choi M H, et al. Clin Chim Acta, 2009, 400(1/2): 63.
11. Park KS, Lee HY, Lee S Y, et al. FEBS Lett, 2007, 581: 4411.
12. Shan L, Davis L, Hazen S L. Clin Chem, 2007, 53(6): A110.
13. Shan L, Hazeh S L. USA Patent, US2007196875-A1. [2007-08-23].
14. Brites PP, Waterham H R, Wanders R J A. BBA-Mol Cell Biol L, 2004, 1636(2/3): 219.
15. Park K S, Kim M K, Im D S, et al. Biochem Pharmacol, 2007, 73(5): 675.
16. Mills G B, Moolenaar W H. Nat Rev Cancer, 2003, 3(8): 582.
17. Fang X J, Schummer M, Mao M L, et al. BBA-Mol Cell Biol L, 2002, 1582(1/2/3): 257.
18. Ren J, Xiao Y J, Singh L S, et al. Cancer Res, 2006, 66(6): 3006.
19. Eliyahu G, Kreizman T, Degani H. Int J Cancer, 2007, 120(8): 1721.
20. Mansilla F, da Costa K A, Wang S, et al. J Mol Med-Jmm, 2009, 87(l): 85.
21. Kang D W, Park M H, Lee Y J, et al. Int J Cancer, 2011, 128(4): 805.
22. Mansilla F, Wang S, Da Costa K A, et al. Proc Am Assoc Cancer Res, 2007, 48: 88.
23. Alexander M, Schlesinger M, Wantscheff P, et al. Int J Clin Pharm Th, 2011, 49(1): 75.
24. Meleh M, Pozlep B, Mlakar A, et al. J Chromatogr B, 2007, 858(1/2): 287.
25. Sedlakova I, Vavrova J, Tosner J, et al. Tumor Biol, 2011, 32(2): 311.
26. Wang C, Xie S G, Yang J, et al. Anal Chim Acta, 2004, 525(1): 1.
27. Yin P Y, Wan D F, Zhao C X, et al. Mol Biosyst, 2009, 5(8): 868.
28. Dong J, Cai X M, Zhao L L, et al. Metabolomics, 2010, 6(4): 478.
29. Zhao Z, Xiao Y, Elson P, et al. J Clin Oncol, 2007, 25(19): 2696.
30. Chen W X, Wu X H, Wang P, et al. Chin J Ultrasonogr, 2006, 15(3): 205.
31. Mangold H K, Weber N. Lipids, 1987, 22(11): 789.
32. McHowat J, Liu S, Creer M H. Am J Physiol-Cell Ph, 1998, 274(6): C1727.
33. Lee T C, Qian C G, Snyder F. Arch Biochem Biophys, 1991, 286(2): 498.